IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0.278. It has been cited 4 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0.0366
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
NIGMS NIH HHS
Grant: U54 GM104940
NCI NIH HHS
Grant: R25 CA214272
National Institutes of Health
Grant: 1P20CA192994-01A1
1/2: Partnership to study racial/ethnic differences in GI cancer biology
National Institutes of Health
Stony Brook University
FWCI
0.23
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals